Bladder cancer can develop without causing someone to feel noticeably sick, which is why recognizing potential warning signs ...
From fronting The Jaggerz to scoring solo rock classics, the legendary Pennsylvania musician died following a battle with ...
The study enrolled 25 patients with high-grade bladder cancer that had come back after earlier BCG treatment. Their median ...
ASTRO’s first bladder cancer guideline recommends trimodal therapy as a curative option for selected patients and defines ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today provided a summary of key findings from the European Society for Medical Oncology (ESMO) Congress 2026.
A gradient boosting machine model built on SEER data from 2,117 patients outperformed TNM staging in predicting survival in ...
Donnie Iris called his retirement a “meaningful and fitting moment” just two weeks before his death at 83. The Pittsburgh ...
The U.S. Food and Drug Administration has expanded the approved use of Anktiva (nogapendekin alfa inbakicept-pmln), given ...
Visugromab combined with PD-1 inhibitor nivolumab demonstrated higher response rates versus nivolumab alone across primary ...
The phase 3 VOLGA trial looks at perioperative durvalumab plus enfortumab vedotin, with and without tremelimumab, for muscle-invasive bladder cancer.
Anktiva is now approved for BCG-unresponsive papillary-only bladder cancer. Here’s what the bladder-sparing option involves, ...
VOLGA was conducted in patients with MIBC ineligible or unwilling to take platinum-based chemotherapy, who received PD-L1 inhibitor Imfinzi (durvalumab) before and after surgery to remove the tumour, ...